Improving diagnosis and treatment of lid disease

Not Applicable

• Conditions: Meibomian gland dysfunction; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12608000342314
• Lead Sponsor: Department of Optometry and Vision Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-07-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Symptoms and signs of meibomian gland dysfunction

Exclusion Criteria

1: major systemic or ophthalmic disease other than MGD
2: history of anterior eye surgery
3: marginal eyelid disease under treatment at the time of presentation
- contact lens wearers

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Therapies for meibomian gland dysfunction will be optimised on the basis of the tear film evaporation rate.[30 minutes and 1 hour following intervention]

Secondary Outcome Measures

Name	Time	Method
Secondary outcome is the temperature profile of the ocular surface and adnexa, measured with a non-contact infra-red thermographer[30 minutes and 1 hour following intervention]